drugset / Trial / NCT00256334

Resveratrol for Patients With Colon Cancer

NCT00256334

NaSingle-groupOpen-labelTreatment

Summary

Resveratrol is purported to possess cancer preventive activity, especially for colon cancer, though its mechanisms of action are not well defined. Resveratrol is found in the skin of grapes and has anti-oxidative and pro-apoptotic effects on cancer cell lines in vitro. The main dietary sources of resveratrol are grapes, grape products, and red wine, and small amounts may be found in mulberries. A prior report and compelling preliminary data from our laboratory suggest that resveratrol modulates Wnt signaling, a signaling pathway which is activated in over 85% of colon cancers. In this proposal, studies were performed to define the actions of resveratrol on the Wnt signaling pathway in a clinical trial in which patients with colon cancer received treatment with Resveratrol, and correlative laboratory studies examined its effects directly on colon cancer and normal colonic mucosa. These studies provided data on the mechanisms of resveratrol action and provided a foundation for future prevention trials, correlative studies and therapeutic clinical research with this agent.

Timeline

Start
2005-07
Primary completion
2008-12
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Grape Powder Unknown 125 mg Oral
Subject Grape Powder Unknown 80 g Oral
Subject Grape Powder Unknown 120 g Oral
Subject Resveratrol Small molecule 20 mg Oral
Subject Resveratrol Small molecule 80 mg Oral
Subject Resveratrol Small molecule 160 mg Oral

Indications